
Immunic, Inc.: updates and filings
Price
$6.99
November 20, 2026Market cap $95M
What Ploutos Investor adds for Immunic
Part of Ploutos Investor, €9.99 a month
- The full history: 14 fiscal years, from 2012
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
What comes next, and what happened
Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.
November 2026
September 2026
August 2026
May 2026
Its SEC filings
What it has filed lately, newest first, linked to the document itself.
- Nov 16, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Nov 16, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Nov 13, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- Nov 13, 2026Results of operationsForm8-K
- Nov 13, 2026Quarterly reportfor the period to Sep 30, 2026Form10-Q
- Nov 5, 2026Regulation FD disclosureForm8-K
- Nov 2, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Oct 1, 2026Shares registered for employeesFormS-8
- Sep 11, 2026Officer or director changeForm8-K
- Sep 9, 2026Regulation FD disclosureForm8-K
- Aug 14, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- Aug 14, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Aug 14, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Aug 13, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Aug 12, 2026Shares registered for employeesFormS-8
- Aug 11, 2026Results of operations, officer or director change, Regulation FD disclosureForm8-K
- Aug 11, 2026Quarterly reportfor the period to Jun 30, 2026Form10-Q
- Aug 6, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Aug 4, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- Jul 16, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Jul 14, 2026Regulation FD disclosureForm8-K
- Jul 6, 2026Officer or director changeForm8-K
- Jun 29, 2026Officer or director change, shareholder voteForm8-K
- May 29, 2026Annual meeting proxy statementFormDEF 14A
- May 28, 2026Regulation FD disclosureForm8-K
| Filed | Form | What it is | Filing |
|---|---|---|---|
| Nov 16, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Nov 16, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Nov 13, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| Nov 13, 2026 | 8-K | Results of operations | Document |
| Nov 13, 2026 | 10-Q | Quarterly reportfor the period to Sep 30, 2026 | Document |
| Nov 5, 2026 | 8-K | Regulation FD disclosure | Document |
| Nov 2, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Oct 1, 2026 | S-8 | Shares registered for employees | Document |
| Sep 11, 2026 | 8-K | Officer or director change | Document |
| Sep 9, 2026 | 8-K | Regulation FD disclosure | Document |
| Aug 14, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| Aug 14, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Aug 14, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Aug 13, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Aug 12, 2026 | S-8 | Shares registered for employees | Document |
| Aug 11, 2026 | 8-K | Results of operations, officer or director change, Regulation FD disclosure | Document |
| Aug 11, 2026 | 10-Q | Quarterly reportfor the period to Jun 30, 2026 | Document |
| Aug 6, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Aug 4, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| Jul 16, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Jul 14, 2026 | 8-K | Regulation FD disclosure | Document |
| Jul 6, 2026 | 8-K | Officer or director change | Document |
| Jun 29, 2026 | 8-K | Officer or director change, shareholder vote | Document |
| May 29, 2026 | DEF 14A | Annual meeting proxy statement | Document |
| May 28, 2026 | 8-K | Regulation FD disclosure | Document |
From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC, since Feb 18, 2004.
The full analysis
What do Immunic's filings show?
The filings are where every one of Immunic's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.